Solid 1H24 earnings, better NEV outlook
Building Better Formal Tvet Systems
Better margins despite cautious sales growth
–Better margin outlook, with Bigo to bottom out
Better Results through Learning and Adaptation for a Better World Bank Group
–3Q23 earnings beat on better product mix and record-high GPM
FY22 results below; GPM recovery on better product mix
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines
Better 2H23 and FY24 as Mexico to turn profitable
China Property Sector–NBS Aug data in-line, expect better recovery in Sep-Oct but sustainability is uncertain